Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.14 billion.
Market Cap
1.12T
Revenue
110.14B
Profits
-39.64B
PE Ratio
n/a
Profit Margin
-35.99%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.84B | 0.36% | 571,020 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.50B | 0.26% | 316,797 | 14.34B |
| 3 | ARGX | argenx SE | 44.42B | 2.03% | 224,618 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.81B | -0.17% | 406,046 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.59B | 0.98% | 1,638,071 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 34.29B | 4.12% | 224,377 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 28.07B | 1.44% | 2,634,812 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.57B | 1.14% | 422,215 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.98B | 0.79% | 3,932,856 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 19.83B | -1.57% | 6,263,525 | 1.94B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.30B | 0.12% | 1,332,840 | - |
| 12 | INCY | Incyte Corporation | 18.78B | 0.27% | 697,130 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.63B | 1.57% | 490,456 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.69B | -0.05% | 1,535,390 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.35B | -0.30% | 1,531,989 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.08B | 0.27% | 274,299 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.47B | 0.56% | 992,108 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.13B | 0.98% | 281,294 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.66B | 0.20% | 416,392 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.42B | 2.52% | 1,046,863 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.98B | 1.03% | 862,910 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.31B | 3.22% | 902,714 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.95B | -0.24% | 307,855 | 7.46M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.85B | 0.81% | 1,078,419 | 1.09B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.78B | 1.57% | 351,004 | 638.50M |
| 26 | PCVX | Vaxcyte, Inc. | 8.45B | 1.05% | 1,568,556 | - |
| 27 | TECH | Bio-Techne Corporation | 8.40B | 2.79% | 1,572,112 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.26B | 2.59% | 741,949 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.21B | 1.09% | 1,682,086 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.77B | 1.52% | 777,976 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.54B | -0.14% | 285,348 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.38B | -6.84% | 16,466,968 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.97B | 2.52% | 361,241 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | -0.04% | 721,413 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.60B | -1.91% | 345,605 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.51B | 3.80% | 126,319 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.22B | 0.01% | 290,853 | - |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.04% | 6,756,675 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 1.09% | 571,730 | 189.76M |
| 40 | CNTA | Centessa Pharmaceuticals plc | 5.82B | 0.33% | 9,670,449 | 15.00M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.72B | -7.72% | 7,356,069 | - |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.70B | 1.09% | 461,332 | 1.73B |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.65B | 0.08% | 1,969,030 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.65B | 1.34% | 454,057 | 521.31M |
| 45 | CGON | CG Oncology, Inc. | 5.62B | -1.60% | 750,897 | 4.04M |
| 46 | CELC | Celcuity Inc. | 5.49B | -0.46% | 476,919 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | -2.36% | 774,108 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.36B | 6.04% | 1,629,632 | 812.03M |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.16B | 0.39% | 23,659,476 | 1.00B |
| 50 | ERAS | Erasca, Inc. | 5.12B | 1.79% | 3,423,288 | - |
| 51 | IMVT | Immunovant, Inc. | 5.11B | 1.17% | 393,745 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.99B | 1.63% | 1,304,857 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.68B | 2.59% | 879,994 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 1,818,993 | 634.21M |
| 55 | CORT | Corcept Therapeutics Incorporated | 4.52B | 5.33% | 1,026,525 | 761.41M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.50B | 1.24% | 694,567 | 2.04M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.00B | 0.49% | 114,737 | 268.09M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.85B | -2.72% | 348,414 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.82B | 0.36% | 579,614 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.81B | 1.23% | 1,678,308 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -0.47% | 961,476 | 1.07B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.77B | 2.41% | 546,509 | 22.50M |
| 63 | GPCR | Structure Therapeutics Inc. | 3.60B | 5.35% | 1,061,357 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | 4.51% | 1,214,062 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.50B | 4.64% | 766,875 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.11B | 2.03% | 1,114,151 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.07B | -3.55% | 139,689 | 803.79M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.03B | 1.39% | 1,650,522 | 62.38M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | -0.04% | 636,566 | 588.99M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.01B | 0.50% | 1,072,084 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | -0.20% | 206,415 | 451.36M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | 1.61% | 778,572 | 376.07M |
| 73 | ALMS | Alumis Inc. | 2.95B | 5.22% | 1,116,957 | 24.05M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.94B | 2.46% | 995,854 | - |
| 75 | TVTX | Travere Therapeutics, Inc. | 2.91B | 6.19% | 1,441,298 | 490.73M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.87B | -1.89% | 461,917 | 218.71M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.74B | 1.16% | 1,014,368 | 247.00M |
| 78 | KOD | Kodiak Sciences Inc. | 2.58B | 9.84% | 2,070,299 | - |
| 79 | IMNM | Immunome, Inc. | 2.55B | 2.97% | 740,961 | 6.94M |
| 80 | ORKA | Oruka Therapeutics, Inc. | 2.50B | 2.73% | 626,634 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.47B | 1.33% | 498,261 | - |
| 82 | AAPG | Ascentage Pharma Group International | 2.44B | 9.61% | 6,991 | 82.08M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.44B | 3.04% | 1,511,968 | 139.74M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.93% | 1,376,188 | 2.20B |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.28B | -2.78% | 586,936 | - |
| 86 | ZLAB | Zai Lab Limited | 2.27B | 7.18% | 788,066 | 460.16M |
| 87 | MANE | Veradermics, Incorporated | 2.26B | -3.96% | 399,753 | - |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | 3.82% | 1,510,682 | 276.98M |
| 89 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.07% | 787,522 | 158.18M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.19B | -1.88% | 717,277 | - |
| 91 | NKTR | Nektar Therapeutics | 2.17B | 5.35% | 912,681 | 55.23M |
| 92 | ADMA | ADMA Biologics, Inc. | 2.17B | 1.33% | 4,560,443 | 510.17M |
| 93 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | 2.40% | 1,190,860 | 172.35M |
| 94 | CLDX | Celldex Therapeutics, Inc. | 2.09B | -1.07% | 227,802 | 1.55M |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 2.09B | 1.58% | 951,872 | 673.00M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.07B | 0.52% | 523,272 | - |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 3.98% | 974,284 | 283.06M |
| 98 | DFTX | Definium Therapeutics, Inc. | 2.03B | 7.83% | 2,106,757 | - |
| 99 | MESO | Mesoblast Limited | 2.01B | 2.73% | 286,425 | 65.38M |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 0.68% | 960,908 | 54.03M |
| 101 | GLPG | Galapagos NV | 1.96B | -0.87% | 276,981 | 1.31B |
| 102 | VRDN | Viridian Therapeutics, Inc. | 1.96B | -1.94% | 1,894,977 | 70.85M |
| 103 | ZYME | Zymeworks Inc. | 1.90B | 3.15% | 384,356 | 105.97M |
| 104 | PHVS | Pharvaris N.V. | 1.90B | 3.72% | 305,551 | - |
| 105 | RLAY | Relay Therapeutics, Inc. | 1.89B | 6.13% | 1,337,875 | 15.36M |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.88B | -2.38% | 461,692 | 184.42M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.86B | 3.37% | 314,011 | - |
| 108 | SLNO | Soleno Therapeutics, Inc. | 1.86B | 7.77% | 2,287,456 | 190.41M |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.82B | -1.42% | 1,772,847 | 51.95M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.75B | -0.07% | 1,332,968 | 11.13M |
| 111 | INVA | Innoviva, Inc. | 1.74B | 0.60% | 343,206 | 411.33M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.72B | 8.00% | 158,187 | 31.89M |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.70B | -4.82% | 190,250 | - |
| 114 | VCEL | Vericel Corporation | 1.68B | 2.33% | 417,274 | 276.26M |
| 115 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | 0.98% | 8,446,190 | 74.68M |
| 116 | ANAB | AnaptysBio, Inc. | 1.62B | 1.39% | 930,045 | 234.60M |
| 117 | OCS | Oculis Holding AG | 1.61B | 2.48% | 312,717 | 1.51M |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | -0.50% | 440,688 | 868.45M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -0.26% | 599,301 | 83.98M |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 4.52% | 2,181,878 | 67.67M |
| 121 | IMCR | Immunocore Holdings plc | 1.55B | 1.09% | 204,068 | 400.02M |
| 122 | NUVB | Nuvation Bio Inc. | 1.54B | 4.66% | 1,949,680 | 62.90M |
| 123 | MBX | MBX Biosciences, Inc. | 1.52B | 6.85% | 220,651 | - |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.02% | 129,889 | - |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.51B | -3.61% | 102,170 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.49B | 1.50% | 4,398,416 | 407.32M |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.49B | -3.02% | 1,019,269 | - |
| 128 | VIR | Vir Biotechnology, Inc. | 1.46B | 2.12% | 1,420,170 | 68.56M |
| 129 | NBTX | Nanobiotix S.A. | 1.44B | 9.72% | 123,497 | 11.93M |
| 130 | BHVN | Biohaven Ltd. | 1.44B | 12.88% | 2,304,077 | - |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.43B | -3.35% | 670,306 | 2.50M |
| 132 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | -1.71% | 7,395,612 | 263.50M |
| 133 | SVRA | Savara Inc. | 1.41B | 1.65% | 693,183 | - |
| 134 | PGEN | Precigen, Inc. | 1.38B | 0.52% | 3,584,010 | 9.68M |
| 135 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | 3.28% | 1,660,688 | 123.67M |
| 136 | IMTX | Immatics N.V. | 1.34B | 1.73% | 237,477 | 56.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.34B | 3.67% | 1,894,287 | 4.09M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | 2.48% | 609,145 | - |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.33B | 2.11% | 350,773 | - |
| 140 | NVAX | Novavax, Inc. | 1.31B | -1.11% | 1,873,812 | 1.12B |
| 141 | WVE | Wave Life Sciences Ltd. | 1.30B | -4.83% | 2,967,732 | 42.73M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | -2.91% | 1,102,745 | 9.77M |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | -0.14% | 673,537 | - |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.20B | -10.46% | 3,641,802 | - |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.19B | 2.51% | 1,231,582 | 10.00M |
| 146 | DBVT | DBV Technologies S.A. | 1.16B | 0.05% | 243,151 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.13B | 1.59% | 1,682 | 376.13M |
| 148 | SEPN | Septerna, Inc. | 1.09B | 0.92% | 120,628 | 45.95M |
| 149 | EYPT | EyePoint, Inc. | 1.08B | 0.47% | 523,150 | 31.37M |
| 150 | ABCL | AbCellera Biologics Inc. | 1.07B | 1.15% | 1,404,982 | 75.13M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.07B | 4.77% | 933,233 | - |
| 152 | GERN | Geron Corporation | 1.05B | 9.73% | 15,141,454 | 183.88M |
| 153 | IVA | Inventiva S.A. | 1.05B | -4.14% | 283,328 | 9.31M |
| 154 | QURE | uniQure N.V. | 1.04B | 1.41% | 1,004,231 | 16.10M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | 3.45% | 1,496,248 | 291.85M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -1.94% | 795,978 | 73.62M |
| 157 | CTMX | CytomX Therapeutics, Inc. | 1.00B | -1.38% | 2,732,024 | 76.20M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 994.37M | 1.26% | 103,475 | 1.30M |
| 159 | CMPX | Compass Therapeutics, Inc. | 941.86M | -1.13% | 1,064,141 | 850.00K |
| 160 | AKTS | Aktis Oncology, Inc. | 938.86M | -5.06% | 188,191 | 6.50M |
| 161 | XNCR | Xencor, Inc. | 919.67M | 3.98% | 754,732 | 125.58M |
| 162 | URGN | UroGen Pharma Ltd. | 917.66M | 4.84% | 351,825 | 109.79M |
| 163 | GHRS | GH Research PLC | 912.76M | 4.66% | 98,992 | - |
| 164 | MPLT | MapLight Therapeutics, Inc. | 908.22M | 1.48% | 102,914 | - |
| 165 | FTRE | Fortrea Holdings Inc. | 892.93M | 1.38% | 480,457 | 2.72B |
| 166 | JANX | Janux Therapeutics, Inc. | 880.23M | 4.10% | 586,946 | 10.00M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 878.61M | 0.36% | 683,808 | 175.11M |
| 168 | ABUS | Arbutus Biopharma Corporation | 877.70M | -0.22% | 658,283 | 14.08M |
| 169 | OMER | Omeros Corporation | 866.47M | 13.97% | 3,564,317 | - |
| 170 | ANNX | Annexon, Inc. | 858.54M | -3.43% | 1,682,206 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 853.42M | -0.77% | 451,244 | - |
| 172 | SGP | SpyGlass Pharma, Inc. | 844.93M | -2.12% | 46,317 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 827.29M | 7.64% | 2,388,230 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 815.13M | -2.46% | 386,054 | 107.46M |
| 175 | EVMN | Evommune, Inc. | 807.53M | -2.48% | 140,009 | 13.00M |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 806.29M | 1.12% | 952,088 | 84.28M |
| 177 | TENX | Tenax Therapeutics, Inc. | 789.21M | -1.88% | 446,634 | - |
| 178 | MNKD | MannKind Corporation | 782.58M | 3.67% | 2,045,988 | 348.97M |
| 179 | ORIC | ORIC Pharmaceuticals, Inc. | 777.78M | -38.83% | 12,306,653 | - |
| 180 | JBIO | Jade Biosciences, Inc. | 762.92M | 10.11% | 1,835,615 | - |
| 181 | ANRO | Alto Neuroscience, Inc. | 747.37M | 4.07% | 208,106 | - |
| 182 | MRVI | Maravai LifeSciences Holdings, Inc. | 745.50M | 2.47% | 1,769,945 | 185.74M |
| 183 | SLS | SELLAS Life Sciences Group, Inc. | 743.47M | -2.13% | 3,633,296 | - |
| 184 | MGTX | MeiraGTx Holdings plc | 739.12M | 4.79% | 939,876 | 81.39M |
| 185 | RLMD | Relmada Therapeutics, Inc. | 737.38M | 1.01% | 1,425,327 | - |
| 186 | KURA | Kura Oncology, Inc. | 735.35M | 2.40% | 971,076 | 67.48M |
| 187 | VOR | Vor Biopharma Inc. | 733.24M | -1.01% | 1,248,366 | - |
| 188 | SLDB | Solid Biosciences Inc. | 725.14M | 2.36% | 627,971 | - |
| 189 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 720.30M | 0.56% | 233,806 | - |
| 190 | DRUG | Bright Minds Biosciences Inc. | 710.76M | -3.38% | 159,612 | - |
| 191 | ARVN | Arvinas, Inc. | 705.49M | 4.06% | 985,663 | 262.60M |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 692.72M | 4.81% | 2,416,436 | 49.80M |
| 193 | DSGN | Design Therapeutics, Inc. | 680.25M | 3.67% | 253,561 | - |
| 194 | CBIO | Crescent Biopharma, Inc. | 663.61M | 8.76% | 362,905 | 10.84M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 657.92M | 3.37% | 43,014 | 116.59M |
| 196 | ALLO | Allogene Therapeutics, Inc. | 633.82M | 6.56% | 3,714,866 | 22.00K |
| 197 | REPL | Replimune Group, Inc. | 631.68M | - | 708,118 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 630.45M | 1.05% | 138,120 | - |
| 199 | OCGN | Ocugen, Inc. | 616.66M | 0.83% | 5,667,943 | 4.41M |
| 200 | PRME | Prime Medicine, Inc. | 616.24M | - | 1,487,652 | 4.63M |
| 201 | DRTS | Alpha Tau Medical Ltd. | 608.59M | -2.19% | 117,508 | - |
| 202 | MDXG | MiMedx Group, Inc. | 591.30M | 0.76% | 939,883 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 583.77M | 0.58% | 89,447 | - |
| 204 | ZURA | Zura Bio Limited | 579.72M | 2.69% | 385,892 | - |
| 205 | AGMB | AgomAb Therapeutics NV | 570.22M | 11.53% | 75,398 | - |
| 206 | ACRS | Aclaris Therapeutics, Inc. | 568.49M | 9.07% | 1,004,733 | 7.83M |
| 207 | VALN | Valneva SE | 564.95M | 1.28% | 211,821 | 205.07M |
| 208 | EIKN | Eikon Therapeutics, Inc. | 561.44M | -1.70% | 58,768 | - |
| 209 | CRMD | CorMedix Inc. | 554.14M | 3.24% | 792,540 | 311.71M |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 550.71M | 0.64% | 384,095 | 106.47M |
| 211 | PRTA | Prothena Corporation plc | 543.17M | 3.81% | 239,522 | 9.68M |
| 212 | PROK | ProKidney Corp. | 532.88M | -1.40% | 663,821 | 893.00K |
| 213 | KYTX | Kyverna Therapeutics, Inc. | 532.01M | 1.97% | 652,295 | - |
| 214 | YDES | YD Bio Limited | 522.48M | -3.51% | 17,521 | 510.36K |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 509.49M | 2.00% | 159,418 | 294.28M |
| 216 | VTVT | vTv Therapeutics Inc. | 504.82M | 2.57% | 26,278 | 17.00K |
| 217 | CTNM | Contineum Therapeutics, Inc. | 503.66M | 3.29% | 98,366 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 502.86M | 5.80% | 422,169 | 85.21M |
| 219 | UPB | Upstream Bio, Inc. | 501.75M | 2.44% | 473,954 | 2.85M |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 499.50M | -2.22% | 368,866 | 80.00M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 494.34M | 5.73% | 47,763 | 36.00K |
| 222 | TRDA | Entrada Therapeutics, Inc. | 486.00M | 6.97% | 156,580 | 25.42M |
| 223 | LRMR | Larimar Therapeutics, Inc. | 483.06M | 3.33% | 938,981 | - |
| 224 | ABSI | Absci Corporation | 482.78M | 5.17% | 2,594,279 | 2.80M |
| 225 | ADCT | ADC Therapeutics SA | 479.59M | 0.67% | 500,049 | 81.36M |
| 226 | VSTM | Verastem, Inc. | 471.67M | 1.32% | 2,168,793 | 30.91M |
| 227 | ASMB | Assembly Biosciences, Inc. | 460.97M | 4.72% | 45,323 | 72.30M |
| 228 | STTK | Shattuck Labs, Inc. | 458.73M | -0.31% | 273,279 | 1.00M |
| 229 | IMMX | Immix Biopharma, Inc. | 458.67M | -4.94% | 564,797 | - |
| 230 | AVIR | Atea Pharmaceuticals, Inc. | 452.54M | 5.58% | 509,309 | - |
| 231 | ENGN | enGene Holdings Inc. | 449.50M | -1.47% | 91,777 | - |
| 232 | RGNX | REGENXBIO Inc. | 444.90M | 2.86% | 361,229 | 170.44M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.37M | 1.66% | 36,835 | - |
| 234 | NAUT | Nautilus Biotechnology, Inc. | 435.38M | -11.34% | 384,506 | - |
| 235 | AURA | Aura Biosciences, Inc. | 434.30M | 1.20% | 199,514 | - |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 430.08M | 1.13% | 814,291 | - |
| 237 | FBRX | Forte Biosciences, Inc. | 429.20M | -7.07% | 244,380 | - |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 411.69M | 0.80% | 753,731 | 216.11M |
| 239 | STRO | Sutro Biopharma, Inc. | 410.87M | -0.44% | 77,918 | 102.48M |
| 240 | ALT | Altimmune, Inc. | 406.58M | 1.46% | 1,374,485 | 41.00K |
| 241 | IPSC | Century Therapeutics, Inc. | 401.68M | -1.11% | 740,982 | 109.16M |
| 242 | XFOR | X4 Pharmaceuticals, Inc. | 400.05M | 6.54% | 349,560 | 35.11M |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 398.54M | 1.27% | 490,939 | 14.56M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 397.36M | 2.23% | 2,726,009 | - |
| 245 | XOMA | XOMA Royalty Corporation | 393.81M | 5.36% | 136,075 | 52.15M |
| 246 | DNA | Ginkgo Bioworks Holdings, Inc. | 391.15M | 9.62% | 732,709 | 170.16M |
| 247 | AVTX | Avalo Therapeutics, Inc. | 385.58M | 13.33% | 577,638 | 59.00K |
| 248 | ARMP | Armata Pharmaceuticals, Inc. | 378.78M | 0.98% | 24,005 | 4.90M |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 378.12M | 3.17% | 108,952 | 66.98M |
| 250 | MNPR | Monopar Therapeutics Inc. | 377.80M | 3.18% | 91,763 | - |
| 251 | IVVD | Invivyd, Inc. | 377.26M | 2.69% | 1,611,521 | 53.43M |
| 252 | BNTC | Benitec Biopharma Inc. | 371.15M | 1.74% | 61,203 | - |
| 253 | AUTL | Autolus Therapeutics plc | 365.95M | -0.36% | 1,401,393 | 75.39M |
| 254 | CADL | Candel Therapeutics, Inc. | 363.30M | 1.22% | 771,301 | - |
| 255 | NAGE | Niagen Bioscience, Inc. | 362.72M | 2.49% | 484,705 | 129.42M |
| 256 | NMRA | Neumora Therapeutics, Inc. | 359.53M | 1.28% | 1,080,696 | - |
| 257 | PRTC | PureTech Health plc | 353.06M | 3.57% | 575 | 6.39M |
| 258 | PLYX | Polaryx Therapeutics, Inc. | 351.29M | -1.85% | 214,802 | - |
| 259 | DMAC | DiaMedica Therapeutics Inc. | 347.54M | -4.73% | 148,468 | - |
| 260 | BCYC | Bicycle Therapeutics plc | 346.44M | 7.11% | 408,837 | 72.59M |
| 261 | IMRX | Immuneering Corporation | 345.25M | 1.33% | 378,675 | - |
| 262 | PBYI | Puma Biotechnology, Inc. | 344.18M | 5.87% | 259,170 | 228.37M |
| 263 | IRD | Opus Genetics, Inc. | 343.65M | 6.15% | 414,449 | 14.20M |
| 264 | NGEN | NervGen Pharma Corp. | 339.31M | 13.00% | 175,972 | - |
| 265 | NGNE | Neurogene Inc. | 333.00M | 6.06% | 57,430 | 925.00K |
| 266 | CLYM | Climb Bio, Inc. | 327.45M | 0.07% | 476,519 | - |
| 267 | RZLT | Rezolute, Inc. | 324.60M | 2.46% | 1,290,822 | - |
| 268 | GLSI | Greenwich LifeSciences, Inc. | 323.64M | -2.75% | 82,613 | - |
| 269 | SRZN | Surrozen, Inc. | 320.88M | -4.10% | 24,144 | 3.48M |
| 270 | PALI | Palisade Bio, Inc. | 313.52M | 8.00% | 4,469,411 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 305.91M | 6.85% | 944,192 | 1.00 |
| 272 | CABA | Cabaletta Bio, Inc. | 300.57M | 0.37% | 1,390,242 | - |
| 273 | LENZ | LENZ Therapeutics, Inc. | 292.38M | 1.91% | 921,763 | 19.09M |
| 274 | PRLD | Prelude Therapeutics Incorporated | 289.70M | 2.63% | 115,491 | 12.14M |
| 275 | ANL | Adlai Nortye Ltd. | 287.82M | 12.72% | 432,243 | -1.35M |
| 276 | NBP | NovaBridge Biosciences | 287.07M | 1.22% | 1,640,542 | - |
| 277 | FHTX | Foghorn Therapeutics Inc. | 285.87M | 1.88% | 55,822 | 30.91M |
| 278 | AVXL | Anavex Life Sciences Corp. | 285.43M | 0.33% | 987,998 | - |
| 279 | OVID | Ovid Therapeutics Inc. | 282.87M | -3.38% | 1,100,683 | 7.25M |
| 280 | ALEC | Alector, Inc. | 277.01M | 16.74% | 2,745,610 | 21.05M |
| 281 | ACIU | AC Immune SA | 274.29M | 0.55% | 161,121 | 4.51M |
| 282 | SLGL | Sol-Gel Technologies Ltd. | 273.03M | 5.43% | 52,267 | 19.39M |
| 283 | SABS | SAB Biotherapeutics, Inc. | 271.62M | 0.91% | 222,501 | 114.70K |
| 284 | TARA | Protara Therapeutics, Inc. | 270.69M | -3.93% | 478,967 | - |
| 285 | CCCC | C4 Therapeutics, Inc. | 262.97M | 2.47% | 1,918,229 | 35.95M |
| 286 | ABEO | Abeona Therapeutics Inc. | 261.28M | 2.23% | 584,319 | 5.82M |
| 287 | ALXO | ALX Oncology Holdings Inc. | 260.58M | -1.25% | 293,859 | - |
| 288 | CHRS | Coherus Oncology, Inc. | 259.31M | 2.37% | 562,980 | 42.17M |
| 289 | SLN | Silence Therapeutics plc | 257.43M | 3.42% | 179,588 | 559.00K |
| 290 | EDIT | Editas Medicine, Inc. | 255.45M | 5.67% | 1,753,995 | 40.52M |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 254.27M | 2.24% | 70,488 | 33.48M |
| 292 | CLLS | Cellectis S.A. | 251.93M | 7.89% | 34,985 | 79.59M |
| 293 | HELP | Cybin Inc. | 247.18M | 2.92% | 592,786 | - |
| 294 | NERV | Minerva Neurosciences, Inc. | 244.50M | -6.22% | 117,941 | - |
| 295 | CNTX | Context Therapeutics Inc. | 240.72M | - | 245,174 | - |
| 296 | VYGR | Voyager Therapeutics, Inc. | 237.21M | 3.11% | 382,631 | 40.37M |
| 297 | KROS | Keros Therapeutics, Inc. | 233.65M | 7.34% | 441,761 | 244.06M |
| 298 | ENLV | Enlivex Ltd. | 231.84M | 5.00% | 427,492 | - |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 226.76M | -3.08% | 806,002 | - |
| 300 | CAMP | Camp4 Therapeutics Corporation | 226.63M | -1.02% | 21,360 | 3.50M |
| 301 | OABI | OmniAb, Inc. | 226.58M | -0.32% | 341,454 | 18.67M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 223.41M | 1.81% | 627,005 | 82.03M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 217.54M | 2.60% | 100,214 | 44.64M |
| 304 | ADAG | Adagene Inc. | 217.51M | 17.73% | 192,929 | 103.20K |
| 305 | MDWD | MediWound Ltd. | 211.12M | 2.02% | 74,757 | 16.96M |
| 306 | CGEN | Compugen Ltd. | 208.02M | 3.29% | 200,476 | 72.76M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 202.40M | -1.16% | 22,875 | - |
| 308 | ELTX | Elicio Therapeutics, Inc. | 196.65M | - | 35,190 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.75M | 0.22% | 342,144 | 13.11M |
| 310 | CRBU | Caribou Biosciences, Inc. | 193.27M | 5.26% | 1,064,008 | 11.16M |
| 311 | ABOS | Acumen Pharmaceuticals, Inc. | 184.14M | 8.05% | 608,048 | - |
| 312 | MGNX | MacroGenics, Inc. | 183.68M | - | 323,497 | 149.50M |
| 313 | UNCY | Unicycive Therapeutics, Inc. | 180.83M | 8.89% | 1,019,973 | - |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 179.27M | 2.53% | 519,126 | 52.74M |
| 315 | KRRO | Korro Bio, Inc. | 178.84M | 9.54% | 220,119 | 6.39M |
| 316 | PRQR | ProQR Therapeutics N.V. | 178.59M | 4.63% | 618,203 | 19.19M |
| 317 | MENS | Jyong Biotech Ltd. | 178.41M | 7.91% | 225,733 | - |
| 318 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.19M | 6.39% | 134,349 | - |
| 319 | GALT | Galectin Therapeutics Inc. | 172.14M | -4.30% | 616,412 | - |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 170.72M | 4.72% | 83,071 | 2.80M |
| 321 | SGMT | Sagimet Biosciences Inc. | 170.09M | -0.10% | 271,414 | - |
| 322 | ARTV | Artiva Biotherapeutics, Inc. | 169.06M | 6.21% | 196,706 | 251.00K |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 168.72M | 0.15% | 216,266 | - |
| 324 | ACHV | Achieve Life Sciences, Inc. | 166.91M | 6.63% | 569,009 | - |
| 325 | ZNTL | Zentalis Pharmaceuticals, Inc. | 166.41M | 9.83% | 306,353 | 26.87M |
| 326 | WHWK | Whitehawk Therapeutics, Inc. | 165.66M | 1.74% | 191,604 | 7.15M |
| 327 | TLSA | Tiziana Life Sciences Ltd | 162.08M | 8.55% | 101,998 | - |
| 328 | MIST | Milestone Pharmaceuticals Inc. | 158.22M | 8.40% | 2,386,387 | 1.55M |
| 329 | CDXS | Codexis, Inc. | 157.66M | 6.44% | 1,230,397 | 70.39M |
| 330 | NKTX | Nkarta, Inc. | 156.84M | 4.27% | 691,287 | - |
| 331 | CNTB | Connect Biopharma Holdings Limited | 151.50M | 3.44% | 196,092 | 762.00K |
| 332 | HRTX | Heron Therapeutics, Inc. | 151.26M | 0.27% | 819,899 | 154.90M |
| 333 | IMUX | Immunic, Inc. | 150.03M | 3.60% | 1,587,694 | - |
| 334 | TNYA | Tenaya Therapeutics, Inc. | 148.49M | -1.17% | 1,399,774 | - |
| 335 | DTIL | Precision BioSciences, Inc. | 146.82M | 3.45% | 84,837 | 34.26M |
| 336 | CBUS | Cibus, Inc. | 146.63M | -2.78% | 517,618 | 3.64M |
| 337 | MOLN | Molecular Partners AG | 145.52M | -0.48% | 3,785 | 856.30K |
| 338 | FATE | Fate Therapeutics, Inc. | 143.59M | 2.92% | 577,779 | 6.65M |
| 339 | SPRO | Spero Therapeutics, Inc. | 140.68M | 3.85% | 332,596 | 66.80M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 134.13M | -0.88% | 52,965 | 2.00M |
| 341 | KLRS | Kalaris Therapeutics, Inc. | 134.13M | 1.39% | 27,514 | - |
| 342 | HUMA | Humacyte, Inc. | 133.81M | -0.66% | 4,712,583 | 2.04M |
| 343 | ACOG | Alpha Cognition Inc. | 133.71M | 12.02% | 138,512 | 10.22M |
| 344 | BDTX | Black Diamond Therapeutics, Inc. | 133.48M | 9.39% | 874,128 | 70.00M |
| 345 | KPTI | Karyopharm Therapeutics Inc. | 131.65M | 4.85% | 480,391 | 146.07M |
| 346 | AGEN | Agenus Inc. | 131.13M | 2.25% | 269,714 | 114.20M |
| 347 | EQ | Equillium, Inc. | 127.72M | 1.00% | 287,664 | 4.39M |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 127.70M | -8.99% | 13,216 | 39.99K |
| 349 | ANTX | AN2 Therapeutics, Inc. | 124.36M | 1.17% | 321,011 | - |
| 350 | PMN | ProMIS Neurosciences, Inc. | 123.26M | 8.23% | 9,294 | - |
| 351 | INO | Inovio Pharmaceuticals, Inc. | 120.91M | 0.57% | 415,384 | 65.34K |
| 352 | PEPG | PepGen Inc. | 120.26M | -1.69% | 3,804,554 | - |
| 353 | IPHA | Innate Pharma S.A. | 114.12M | 6.25% | 11,105 | 10.57M |
| 354 | GNLX | Genelux Corporation | 113.15M | 5.37% | 83,525 | 8.00K |
| 355 | CRDF | Cardiff Oncology, Inc. | 110.41M | -0.31% | 516,066 | 593.00K |
| 356 | BMEA | Biomea Fusion, Inc. | 107.73M | -2.61% | 1,155,831 | - |
| 357 | ALDX | Aldeyra Therapeutics, Inc. | 104.72M | 2.96% | 3,556,661 | - |
| 358 | ONCY | Oncolytics Biotech Inc. | 101.17M | 10.77% | 725,938 | - |
| 359 | SGMO | Sangamo Therapeutics, Inc. | 98.87M | 7.74% | 7,338,767 | 39.55M |
| 360 | HURA | TuHURA Biosciences, Inc. | 98.37M | -9.50% | 324,784 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 95.00M | 2.79% | 96,561 | 7.95M |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 94.83M | 4.35% | 86,433 | 35.58M |
| 363 | TTRX | Turn Therapeutics Inc. | 94.81M | 0.63% | 37,057 | - |
| 364 | SEER | Seer, Inc. | 94.50M | -0.30% | 262,707 | 16.58M |
| 365 | LONA | LeonaBio, Inc. | 92.89M | -3.21% | 8,449 | - |
| 366 | PYXS | Pyxis Oncology, Inc. | 92.36M | 0.68% | 177,330 | 13.86M |
| 367 | SPRB | Spruce Biosciences, Inc. | 92.16M | 2.79% | 48,375 | 697.00K |
| 368 | ANIX | Anixa Biosciences, Inc. | 90.28M | 4.36% | 99,815 | - |
| 369 | QTTB | Q32 Bio Inc. | 88.80M | -5.45% | 166,823 | 53.74M |
| 370 | AARD | Aardvark Therapeutics, Inc. | 88.35M | 7.43% | 356,623 | - |
| 371 | VANI | Vivani Medical, Inc. | 86.76M | 2.50% | 165,387 | - |
| 372 | OKYO | OKYO Pharma Limited | 86.07M | 1.86% | 54,305 | - |
| 373 | MCRB | Seres Therapeutics, Inc. | 84.74M | -0.34% | 28,058 | 789.00K |
| 374 | PYPD | PolyPid Ltd. | 84.16M | 0.68% | 55,151 | - |
| 375 | ATYR | aTyr Pharma, Inc. | 84.02M | 9.86% | 1,590,998 | 190.00K |
| 376 | GOSS | Gossamer Bio, Inc. | 83.86M | 8.77% | 8,284,169 | 48.47M |
| 377 | KZIA | Kazia Therapeutics Limited | 83.53M | -1.75% | 203,543 | 1.27M |
| 378 | FLNA | Filana Therapeutics, Inc. | 82.85M | 1.48% | 192,438 | - |
| 379 | MAIA | MAIA Biotechnology, Inc. | 82.51M | -2.86% | 336,557 | - |
| 380 | CSBR | Champions Oncology, Inc. | 82.49M | 3.30% | 6,704 | 57.95M |
| 381 | PLRX | Pliant Therapeutics, Inc. | 81.73M | 4.76% | 423,606 | - |
| 382 | FBIO | Fortress Biotech, Inc. | 81.63M | -5.73% | 366,292 | 62.30M |
| 383 | GANX | Gain Therapeutics, Inc. | 81.32M | -0.77% | 446,217 | - |
| 384 | NRXS | NeurAxis, Inc. | 79.99M | -3.38% | 68,899 | 3.57M |
| 385 | CGTX | Cognition Therapeutics, Inc. | 79.95M | 17.81% | 2,770,613 | - |
| 386 | GRCE | Grace Therapeutics, Inc. | 77.37M | 7.99% | 636,777 | - |
| 387 | RANI | Rani Therapeutics Holdings, Inc. | 76.77M | 4.77% | 1,849,128 | 1.63M |
| 388 | ACET | Adicet Bio, Inc. | 74.38M | 1.62% | 67,374 | - |
| 389 | DWTX | Dogwood Therapeutics, Inc. | 72.80M | 3.30% | 63,340 | - |
| 390 | PMVP | PMV Pharmaceuticals, Inc. | 72.79M | 10.08% | 339,109 | - |
| 391 | GUTS | Fractyl Health, Inc. | 72.39M | -0.33% | 1,741,575 | 3.00K |
| 392 | XBIT | XBiotech Inc. | 71.95M | 0.43% | 9,709 | - |
| 393 | NRXP | NRx Pharmaceuticals, Inc. | 71.85M | 2.11% | 310,922 | 1.23M |
| 394 | PTHS | Pelthos Therapeutics Inc. | 71.47M | 1.38% | 7,550 | 16.80M |
| 395 | CING | Cingulate Inc. | 71.28M | -1.29% | 291,848 | - |
| 396 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.76M | 1.34% | 20,982 | 1.36M |
| 397 | BYSI | BeyondSpring Inc. | 69.49M | 3.05% | 11,168 | 1.88M |
| 398 | EXOZ | eXoZymes, Inc. | 69.30M | 9.85% | 12,954 | -700.00 |
| 399 | MNOV | MediciNova, Inc. | 68.42M | 1.46% | 8,574 | 409.66K |
| 400 | IBIO | iBio, Inc. | 67.36M | 2.63% | 390,961 | 300.00K |
| 401 | ATHE | Alterity Therapeutics Limited | 67.18M | 4.49% | 4,381 | 4.43M |
| 402 | LPCN | Lipocine Inc. | 65.04M | 11.51% | 148,389 | 1.98M |
| 403 | IFRX | InflaRx N.V. | 64.34M | -0.49% | 323,124 | 34.44K |
| 404 | IBO | Impact BioMedical Inc. | 63.79M | -1.40% | 67,997 | 32.00K |
| 405 | ACTU | Actuate Therapeutics, Inc. | 59.51M | -8.39% | 76,740 | - |
| 406 | ANVS | Annovis Bio, Inc. | 59.04M | -6.62% | 445,845 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 58.89M | 2.48% | 584,863 | 10.33M |
| 408 | ICCC | ImmuCell Corporation | 57.89M | 1.11% | 2,578 | 27.64M |
| 409 | HYFT | MindWalk Holdings Corp. | 57.61M | 2.65% | 79,340 | 20.70M |
| 410 | IMA | ImageneBio, Inc. | 56.48M | 1.00% | 20,766 | 800.00K |
| 411 | OKUR | OnKure Therapeutics, Inc. | 56.20M | -0.73% | 228,299 | - |
| 412 | ACRV | Acrivon Therapeutics, Inc. | 55.79M | 3.60% | 510,325 | - |
| 413 | MREO | Mereo BioPharma Group plc | 54.80M | 4.03% | 1,662,645 | 500.00K |
| 414 | KZR | Kezar Life Sciences, Inc. | 54.51M | -0.34% | 62,447 | - |
| 415 | TIL | Instil Bio, Inc. | 54.05M | -3.28% | 17,758 | - |
| 416 | ENTX | Entera Bio Ltd. | 52.22M | 0.90% | 64,080 | 42.00K |
| 417 | RADX | Radiopharm Theranostics Limited | 51.63M | -3.60% | 21,986 | 10.86M |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 50.04M | -0.75% | 282,569 | 25.21M |
| 419 | XLO | Xilio Therapeutics, Inc. | 49.53M | 1.84% | 24,380 | 43.77M |
| 420 | INKT | MiNK Therapeutics, Inc. | 49.31M | -0.24% | 40,888 | - |
| 421 | ALGS | Aligos Therapeutics, Inc. | 48.51M | 5.52% | 57,326 | 2.19M |
| 422 | OSTX | OS Therapies Incorporated | 48.24M | -2.84% | 285,025 | - |
| 423 | EDSA | Edesa Biotech, Inc. | 47.67M | 9.18% | 456,474 | - |
| 424 | ESLA | Estrella Immunopharma, Inc. | 46.93M | 3.77% | 77,427 | - |
| 425 | IMMP | Immutep Limited | 46.53M | 8.69% | 415,675 | 5.28M |
| 426 | LSTA | Lisata Therapeutics, Inc. | 45.25M | - | 42,298 | 170.00K |
| 427 | HOWL | Werewolf Therapeutics, Inc. | 44.71M | 10.50% | 670,880 | 1.14M |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 0.01% | 82,202 | - |
| 429 | SNSE | Sensei Biotherapeutics, Inc. | 44.54M | 11.68% | 46,851 | - |
| 430 | NTRB | Nutriband Inc. | 44.49M | 3.68% | 3,203 | 2.28M |
| 431 | RLYB | Rallybio Corporation | 44.09M | -7.08% | 22,661 | 858.00K |
| 432 | ATOS | Atossa Therapeutics, Inc. | 44.00M | -2.85% | 56,844 | - |
| 433 | RNXT | RenovoRx, Inc. | 43.43M | -4.63% | 383,752 | 1.12M |
| 434 | NBY | NovaBay Pharmaceuticals, Inc. | 42.47M | 7.05% | 192,929 | 10.30M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 42.44M | 9.73% | 61,986 | 120.77M |
| 436 | LITS | Lite Strategy, Inc. | 41.63M | -1.29% | 191,971 | - |
| 437 | CELU | Celularity Inc. | 38.07M | -0.75% | 3,843 | 40.58M |
| 438 | NXTC | NextCure, Inc. | 37.60M | -1.12% | 7,913 | - |
| 439 | CRVO | CervoMed Inc. | 37.08M | 1.65% | 22,952 | 4.01M |
| 440 | PTN | Palatin Technologies, Inc. | 36.77M | 3.33% | 11,106 | 8.96M |
| 441 | VERU | Veru Inc. | 36.11M | 1.81% | 19,544 | 16.89M |
| 442 | RNTX | Rein Therapeutics Inc. | 35.33M | -3.08% | 24,809 | - |
| 443 | PLUR | Pluri Inc. | 35.18M | 3.09% | 1,972 | 1.34M |
| 444 | LGVN | Longeveron Inc. | 33.09M | 8.65% | 1,293,425 | 1.20M |
| 445 | INMB | INmune Bio Inc. | 32.83M | 9.29% | 447,370 | 50.00K |
| 446 | PDSB | PDS Biotechnology Corporation | 32.52M | -1.79% | 99,408 | - |
| 447 | EVAX | Evaxion A/S | 31.69M | 2.15% | 17,382 | 7.53M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 31.00M | -0.17% | 101,821 | 90.00K |
| 449 | DYAI | Dyadic International, Inc. | 30.98M | 3.68% | 37,902 | 3.09M |
| 450 | APLM | Apollomics, Inc. | 30.84M | -9.37% | 3,819 | 6.93M |
| 451 | BCTX | BriaCell Therapeutics Corp. | 29.87M | -2.09% | 73,354 | - |
| 452 | HYPD | Hyperion DeFi, Inc. | 28.92M | -6.67% | 223,705 | 813.46K |
| 453 | KYNB | Kyntra Bio, Inc. | 28.83M | 5.09% | 22,439 | 6.44M |
| 454 | CVM | CEL-SCI Corporation | 27.35M | 5.30% | 47,504 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 27.24M | -4.35% | 1,099,454 | - |
| 456 | DARE | Daré Bioscience, Inc. | 27.23M | 2.75% | 110,721 | 1.03M |
| 457 | SNTI | Senti Biosciences, Inc. | 26.95M | 6.57% | 119,865 | 22.00K |
| 458 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.75M | - | 70,838 | - |
| 459 | TVRD | Tvardi Therapeutics, Inc. | 26.74M | -10.38% | 102,300 | - |
| 460 | PSTV | Plus Therapeutics, Inc. | 26.20M | -6.09% | 18,276,115 | 5.21M |
| 461 | XCUR | Exicure, Inc. | 26.03M | -3.99% | 6,575 | 500.00K |
| 462 | IGC | IGC Pharma, Inc. | 25.97M | 3.04% | 227,100 | 1.11M |
| 463 | ABVC | ABVC BioPharma, Inc. | 25.95M | 8.24% | 131,808 | 797.92K |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 25.71M | 1.97% | 57,205 | - |
| 465 | BOLD | Boundless Bio, Inc. | 25.43M | 3.18% | 34,567 | - |
| 466 | PASG | Passage Bio, Inc. | 25.25M | 0.25% | 15,651 | - |
| 467 | SER | Serina Therapeutics, Inc. | 25.06M | 4.90% | 548,069 | 130.00K |
| 468 | BRNS | Barinthus Biotherapeutics plc | 24.75M | 6.49% | 2,906 | 14.97M |
| 469 | AEON | AEON Biopharma, Inc. | 24.63M | -1.18% | 87,204 | - |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 24.14M | 6.61% | 749,414 | 789.00K |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 23.67M | 7.86% | 52,987 | 14.99M |
| 472 | CYCN | Cyclerion Therapeutics, Inc. | 23.64M | 300.65% | 244,666,275 | 2.07M |
| 473 | TPST | Tempest Therapeutics, Inc. | 23.09M | -1.83% | 91,232 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 23.09M | -5.83% | 604,148 | - |
| 475 | SKYE | Skye Bioscience, Inc. | 22.11M | 7.79% | 543,792 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.01M | 1.54% | 67,544 | 3.55M |
| 477 | OTLK | Outlook Therapeutics, Inc. | 21.73M | 0.92% | 1,239,959 | 205.70K |
| 478 | CRIS | Curis, Inc. | 21.72M | -0.73% | 319,276 | 9.44M |
| 479 | LEXX | Lexaria Bioscience Corp. | 21.28M | 9.62% | 195,217 | 522.00K |
| 480 | NNVC | NanoViricides, Inc. | 20.31M | 3.12% | 112,731 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.28M | 1.84% | 98,266 | 570.00K |
| 482 | CUE | Cue Biopharma, Inc. | 19.57M | -12.83% | 1,253,506 | 27.47M |
| 483 | PLRZ | Polyrizon Ltd. | 19.13M | 2.74% | 33,047 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.96M | -5.84% | 387,884 | 3.94M |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.17M | 3.68% | 123,621 | 320.00K |
| 486 | TVGN | Tevogen Bio Holdings Inc. | 17.69M | -3.33% | 18,250 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 16.75M | -2.20% | 7,662,612 | - |
| 488 | LTRN | Lantern Pharma Inc. | 15.92M | 3.65% | 1,180,903 | - |
| 489 | GNTA | Genenta Science S.p.A. | 15.91M | 1.06% | 15,426 | - |
| 490 | PHIO | Phio Pharmaceuticals Corp. | 15.45M | 9.02% | 391,882 | - |
| 491 | INTS | Intensity Therapeutics, Inc. | 14.96M | 0.17% | 13,236 | - |
| 492 | OSRH | OSR Holdings, Inc. | 14.89M | -3.81% | 952,374 | -90.52K |
| 493 | ICU | SeaStar Medical Holding Corporation | 14.34M | -3.49% | 108,765 | 1.23M |
| 494 | COCP | Cocrystal Pharma, Inc. | 13.92M | - | 23,999 | - |
| 495 | INAB | IN8bio, Inc. | 13.69M | -6.08% | 51,822 | - |
| 496 | TRAW | Traws Pharma, Inc. | 13.57M | -7.17% | 126,675 | 2.85M |
| 497 | BCDA | BioCardia, Inc. | 13.24M | - | 55,513 | 3.00K |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 12.86M | 7.42% | 12,722 | - |
| 499 | GTBP | GT Biopharma, Inc. | 12.63M | -1.94% | 467,399 | - |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 12.40M | -4.28% | 111,512 | - |